“…Low frequencies of resistance to HBEMAU were observed (8), which seems to be in accordance with the fact that probably only a single allowable mutation leads to resistance to the anilinouracil-based compound class. However, to estimate the clinical relevance of this resistance phenomenon, more detailed studies with more strains should be performed.…”